Braskem Signs Agreement with Novonor to Acquire Debt Claims
In a regulatory filing earlier, Braskem informed its shareholders and the market in general that it received over the weekend correspondences from Novonor S.A - Em Recuperacao Judicial and Shine I Fundo de Investimento em Direitos Creditorios de Responsabilidade Limitada, represented by its manager Vortx Capital Gestora De Recursos Ltda., advised by IG4 Sol. Ltda., informing about the execution of a definitive binding agreement between the FIDC and the creditor banks of NSP Investimentos S.A. and other entities of the group Novonor S.A. - Em Recuperacao Judicial to acquire all the credits held by the aforementioned banks against Novonor guaranteed by, among others, fiduciary assignment constituted on the shares issued by the company held by NSP Inv.; and an exclusivity agreement with an initial term of sixty days between FIDC and Novonor regarding a a potential transaction involving the shares issued by Braskem held by NSP Inv. BofA said in a note to investors that it views the news as positive, as it could help address investors' main concern regarding Braskem's investment thesis, which is the company's short-to-medium-term liquidity.
Discover Tomorrow's Bullish Stocks Today
Analyst Views on BAK
About BAK
About the author

Qube Research Discloses 1% Stake in Bakkavor Group PLC
- Stake Disclosure: Qube Research & Technologies Limited disclosed a holding of 5,899,795 cash-settled derivatives in Bakkavor Group PLC, representing a 1% interest, indicating its investment intentions in the company.
- Trading Details: In recent transactions, Qube executed multiple equity swaps of 2p ordinary shares, reducing long positions at prices ranging from 229 to 233.50 pence, reflecting its strategy to navigate market volatility.
- Regulatory Compliance: This disclosure adheres to Rule 8.3 of the Takeover Code, ensuring transparency and compliance, which underscores Qube's commitment to regulatory standards.
- Market Impact: Qube's stake disclosure may influence Bakkavor's market performance, prompting investors to monitor subsequent stock price fluctuations and market reactions.

Qube Research Discloses 1% Stake in Bakkavor Group PLC
- Stake Disclosure: Qube Research & Technologies Limited disclosed a holding of 5,836,498 cash-settled derivatives in Bakkavor Group PLC, representing a 1% stake, indicating its investment interest in the company.
- Trading Details: In recent transactions, Qube increased its long positions through equity swaps at prices ranging from 230.50 to 233.50 pence per share, reflecting its positive outlook on Bakkavor's future performance.
- Regulatory Compliance: This disclosure adheres to Rule 8.3 of the Takeover Code, ensuring market transparency and demonstrating Qube's commitment to compliance and information disclosure.
- Market Impact: Qube's stake disclosure may influence Bakkavor's market performance, prompting investors to monitor subsequent stock price fluctuations and market reactions.






